Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice.
Calcineurin activation ameliorates the dystrophic pathology of hindlimb muscles in mdx mice and decreases their susceptibility to contraction damage. In mdx mice, the diaphragm is more severely affected than hindlimb muscles and more representative of Duchenne muscular dystrophy. The constitutively active calcineurin Aalpha transgene (CnAalpha) was overexpressed in skeletal muscles of mdx (mdx CnAalpha*) mice to test whether muscle morphology and function would be improved. Contractile function of diaphragm strips and extensor digitorum longus and soleus muscles from adult mdx CnAalpha* and mdx mice was examined in vitro. Hindlimb muscles from mdx CnAalpha* mice had a prolonged twitch time course and were more resistant to fatigue. Because of a slower phenotype and a decrease in fiber cross-sectional area, normalized force was lower in fast- and slow-twitch muscles of mdx CnAalpha* than mdx mice. In the diaphragm, despite a slower phenotype and a approximately 35% reduction in fiber size, normalized force was preserved. This was likely mediated by the reduction in the area of the diaphragm undergoing degeneration (i.e., mononuclear cell and connective and adipose tissue infiltration). The proportion of centrally nucleated fibers was reduced in mdx CnAalpha* compared with mdx mice, indicative of improved myofiber viability. In hindlimb muscles of mdx mice, calcineurin activation increased expression of markers of regeneration, particularly developmental myosin heavy chain isoform and myocyte enhancer factor 2A. Thus activation of the calcineurin signal transduction pathway has potential to ameliorate the mdx pathophysiology, especially in the diaphragm, through its effects on muscle degeneration and regeneration and endurance capacity.
Stupka
Nicole
N
Basic and Clinical Myology Laboratory, Department of Physiology, University of Melbourne, Victoria, 3010, Australia.
Schertzer
Jonathan D
JD
Bassel-Duby
Rhonda
R
Olson
Eric N
EN
Lynch
Gordon S
GS
D000818:Animals; D001835:Body Weight / Q000502:physiology; D019703:Calcineurin / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D003094:Collagen / Q000378:metabolism; D003964:Diaphragm / Q000378:metabolism / Q000503:physiopathology; D006614:Hindlimb / Q000502:physiology; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D018101:Mice, Inbred mdx; D018485:Muscle Fibers, Skeletal / Q000502:physiology; D018482:Muscle, Skeletal / Q000502:physiology; D009137:Muscular Dystrophy, Animal / Q000378:metabolism* / Q000503:physiopathology*; D018008:Myogenin / Q000096:biosynthesis; D009929:Organ Size / Q000502:physiology; D010084:Oxidation-Reduction; D010641:Phenotype; D010807:Physical Endurance / Q000502:physiology; D012038:Regeneration / Q000502:physiology; D019076:Transgenes
D018008:Myogenin; D003094:Collagen; D019703:Calcineurin